---
title: "SUBRAMANIAN NACHIAPPAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/de178d36-67b4-55fe-975e-e78b07517c0b
json: https://whiteintel.dev/api/public/dossier/de178d36-67b4-55fe-975e-e78b07517c0b
identifier: sec:0002069599
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SUBRAMANIAN NACHIAPPAN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002069599`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/de178d36-67b4-55fe-975e-e78b07517c0b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/de178d36-67b4-55fe-975e-e78b07517c0b  

## Ownership & control

### Holdings / subsidiaries

- **Atara Biotherapeutics, Inc.** (director) — https://whiteintel.dev/entity/8a5507e4-9c1c-5edd-82c9-7075a400f0ab

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SUBRAMANIAN NACHIAPPAN**. Human view: https://whiteintel.dev/entity/de178d36-67b4-55fe-975e-e78b07517c0b · Structured JSON: https://whiteintel.dev/api/public/dossier/de178d36-67b4-55fe-975e-e78b07517c0b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._